Abstract
Thirty years after the publication of the first report on gene electrotransfer in cultured cells by the delivery of delivering electric pulses, this technology is starting to be applied to humans. In 2008, at the time of the publication of the first edition of this book, reversible cell electroporation for gene transfer and gene therapy (nucleic acids electrotransfer) was at a cross roads in its development. In 5 years, basic and applied developments have brought gene electrotransfer into a new status. Present knowledge on the effects of cell exposure to appropriate electric field pulses, particularly at the level of the cell membrane, is reported here, as an introduction to the large range of applications described in this book. The importance of the models of electric field distribution in tissues and of the correct choice of electrodes and applied voltages is highlighted, as well as the large range of new specialized electrodes, developed also in the frame of the other electroporation-based treatments (electrochemotherapy). Indeed, electric pulses are now routinely applied for localized drug delivery in the treatment of solid tumors by electrochemotherapy. The mechanisms involved in DNA electrotransfer, which include cell electropermeabilization and DNA electrophoresis, are also surveyed: noticeably, the first molecular description of the crossing of a lipid membrane by a nucleic acid was reported in 2012. The progress in the understanding of cell electroporation as well as developments of technological aspects, in silico, in vitro and in vivo, have contributed to bring gene electrotransfer development to the clinical stage. However, spreading of the technology will require not only more clinical trials but also further homogenization of the protocols and the preparation and validation of Standard Operating Procedures.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Escoffre JM, Portet T, Favard C, Teissie J, Dean DS, Rols MP (2011) Electromediated formation of DNA complexes with cell membranes and its consequences for gene delivery. Biochim Biophys Acta 1808:1538–1543
Dean DA, Strong DD, Zimmer WE (2005) Nuclear entry of nonviral vectors. Gene Ther 12:881–890
Breton M, Delemotte L, Silve A, Mir LM, Tarek M (2012) Nanosecond pulsed electric field driven transport of siRNA molecules through lipid membranes: an experimental and computational study. J Am Chem Soc 134:13938–13941
Neumann E, Schaefer-Ridder M, Wang Y, Hofschneider PH (1982) Gene transfer into mouse lyoma cells by electroporation in high electric fields. EMBO J 1:841–845
Daud AI, DeConti RC, Andrews S, Urbas P, Riker AI, Sondak VK, Munster PN, Sullivan DM, Ugen KE, Messina JL, Heller R (2008) Phase I trial of interleukin-12 plasmid electroporation in patients with metastatic melanoma. J Clin Oncol 26:5896–5903
Spanggaard I, Snoj M, Cavalcanti A, Bouquet C, Sersa G, Robert C, Cemazar M, Dam E, Vasseur B, Attali P, Mir LM, Gehl J (2013) Gene electrotransfer of plasmid AMEP in disseminated melanoma: safety and efficacy results of a phase I first-in-man study. Hum Gene Ther Clin Dev 24(3):99–107
Mir LM, Belehradek M, Domenge C, Orlowski S, Poddevin B, Belehradek J Jr, Schwaab G, Luboinski B, Paoletti C (1991) Electrochemotherapy, a novel antitumor treatment : first clinical trial. C R Acad Sci III 313:613–618
Mir LM (2006) Bases and rationale of the electrochemotherapy. Eur J Cancer Suppl 4:38–44
Marty M, Sersa G, Garbay JR, Gehl J, Collins C, Snoj M, Billard V, Geertsen P, Larkin J, Miklavcic D, Pavlovic I, Paulin-Kosir S, Cemazar M, Morsli N, Soden D, Rudolf Z, Robert C, O’Sullivan G, Mir LM (2006) Electrochemotherapy—a simple, highly effective and safe treatment of cutaneous and subcutaneous metastases: results of ESOPE (European Standard Operating Procedures for Electrochemotherapy) study. Eur J Cancer Suppl 4:3–13
Mir LM, Gehl J, Sersa G, Collins C, Garbay JR, Billard V, Geertsen P, Rudolf Z, O’Sullivan G, Marty M (2006) Standard operating procedures of the electrochemotherapy: instructions for the use of bleomycin or cisplatin administered either systemically or locally and electric pulses delivered by the Cliniporator™ by means of invasive or non-invasive electrodes. Eur J Cancer Suppl 4:14–25
Schwan HP (1957) Electrical properties of tissue and cell suspensions. Adv Biol Med Phys 5:147–209
Kotnik T, Miklavcic D (2000) Analytical description of transmembrane voltage induced by electric fields on spheroidal cells. Biophys J 79:670–679
Gimsa J, Wachner D (2001) Analytical description of the transmembrane voltage induced on arbitrarily oriented ellipsoidal and cylindrical cells. Biophys J 81:1888–1896
Teissie J, Knutson VP, Tsong TY, Lane MD (1982) Electric pulse-induced fusion of 3T3 cells in monolayer culture. Science 216:537–8
Mir LM, Banoun H, Paoletti C (1988) Introduction of definite amounts of nonpermeant molecules into living cells after electropermeabilization: direct access to the cytosol. Exp Cell Res 175:15–25
Silve A, Mir LM (2010) Cell electropermeabilisation and small molecules cellular uptake: the electrochemotherapy concept. In: Kee S, Lee E, Gehl J (eds) Electroporation in science and medicine. Springer, New York
Pron G, Belehradek J Jr, Mir LM (1993) Identification of a plasma membrane protein that specifically binds bleomycin. Biochem Biophys Res Commun 194:333–337
Tieleman DP, Leontiadou H, Mark AE, Marrink SJ (2003) Simulation of pore formation in lipid bilayers by mechanical stress and electric fields. J Am Chem Soc 125:6282–6283
Tarek M (2005) Membrane electroporation: a molecular dynamics simulation. Biophys J 88:4045–4053
Fernandez ML, Risk M, Reigada R, Vernier PT (2012) Size-controlled nanopores in lipid membranes with stabilizing electric fields. Biochem Biophys Res Commun 423:325–330
Levine ZA, Vernier PT (2010) Life cycle of an electropore: field-dependent and field-independent steps in pore creation and annihilation. J Membr Biol 236:27–36
Tokman M, Lee JH, Levine ZA, Ho MC, Colvin ME, Vernier PT (2013) Electric field-driven water dipoles: nanoscale architecture of electroporation. PLoS One 8:e61111
Chang DC, Reese TS (1990) Changes in membrane structure induced by electroporation as revealed by rapid-freezing electron microscopy. Biophys J 58:1–12
Davalos RV, Mir LM, Rubinsky B (2005) Tissue ablation with irreversible electroporation. Ann Biomed Eng 33:223–231
Miller L, Leor J, Rubinsky B (2005) Cancer cells ablation with irreversible electroporation. Technol Cancer Res Treat 4:699–705
Al-Sakere B, Bernat C, André F, Connault E, Opolon P, Davalos RV, Mir LM (2007) A study of the immunological response to tumor ablation with irreversible electroporation. Technol Cancer Res Treat 6:301–305
Teissie J, Golzio M, Rols MP (2005) Mechanisms of cell membrane electropermeabilization: a minireview of our present (lack of ?) knowledge. Biochim Biophys Acta 1724:270–280
Lopez A, Rols MP, Teissie J (1988) 31P NMR analysis of membrane phospholipid organization in viable, reversibly electropermeabilized Chinese hamster ovary cells. Biochemistry 27:1222–1228
Mir LM, Bureau MF, Gehl J, Rangara R, Rouy D, Caillaud JM, Delaere P, Branellec D, Schwartz B, Scherman D (1999) High-efficiency gene transfer into skeletal muscle mediated by electric pulses. Proc Natl Acad Sci USA 96:4262–4267
Gehl J, Sorensen TH, Nielsen K, Raskmark P, Nielsen SL, Skovsgaard T, Mir LM (1999) In vivo electroporation of skeletal muscle: threshold, efficacy and relation to electric field distribution. Biochim Biophys Acta 1428:233–240
Satkauskas S, Bureau MF, Puc M, Mahfoudi A, Scherman D, Miklavcic D, Mir LM (2002) Mechanisms of in vivo DNA electrotransfer: respective contributions of cell electropermeabilization and DNA electrophoresis. Mol Ther 5:133–140
Rols MP, Delteil C, Golzio M, Dumond P, Cros S, Teissie J (1998) In vivo electrically mediated protein and gene transfer in murine melanoma. Nat Biotechnol 16:168–171
Suzuki T, Shin BC, Fujikura K, Matsuzaki T, Takata K (1998) Direct gene transfer into rat liver cells by in vivo electroporation. FEBS Lett 425:436–440
Aihara H, Miyazaki J (1998) Gene transfer into muscle by electroporation in vivo. Nat Biotechnol 16:867–870
Poddevin B, Orlowski S, Belehradek J Jr, Mir LM (1991) Very high cytotoxicity of bleomycin introduced into the cytosol of cells in culture. Biochem Pharmacol 42(Suppl):S67–75
Bazile D, Mir LM, Paoletti C (1989) Voltage-dependent introduction of a d[alpha]octothymidylate into electropermeabilized cells. Biochem Biophys Res Commun 159:633–639
Casabianca-Pignède M-R, Mir LM, Le Pecq J-B, Jacquemin-Sablon A (1991) Stability of antiricin antibodies introduced into DC-3F Chinese hamster cells by electropermeabilization. J Cell Pharmacol 2:54–60
Rols MP, Teissie J (1998) Electropermeabilization of mammalian cells to macromolecules: control by pulse duration. Biophys J 75:1415–1423
Teissie J, Ramos C (1998) Correlation between electric field pulse induced long-lived permeabilization and fusogenicity in cell membranes. Biophys J 74:1889–1898
Bureau MF, Gehl J, Deleuze V, Mir LM, Scherman D (2000) Importance of association between permeabilization and electrophoretic forces for intramuscular DNA electrotransfer. Biochim Biophys Acta 1474:353–359
Satkauskas S, Andre F, Bureau MF, Scherman D, Miklavcic D, Mir LM (2005) Electrophoretic component of electric pulses determines the efficacy of in vivo DNA electrotransfer. Hum Gene Ther 16:1194–1201
Faurie C, Phez E, Golzio M, Vossen C, Lesbordes JC, Delteil C, Teissie J, Rols MP (2004) Effect of electric field vectoriality on electrically mediated gene delivery in mammalian cells. Biochim Biophys Acta 1665:92–100
Rebersek M, Faurie C, Kanduser M, Corovic S, Teissie J, Rols MP, Miklavcic D (2007) Electroporator with automatic change of electric field direction improves gene electrotransfer in-vitro. Biomed Eng Online 6:25
Teissie J, Blangero C (1984) Direct experimental evidence of the vectorial character of the interaction between electric pulses and cells in cell electrofusion. Biochim Biophys Acta 775:446–448
Teissie J, Rols MP (1993) An experimental evaluation of the critical potential difference inducing cell membrane electropermeabilization. Biophys J 65:409–413
Kanduser M, Miklavcic D, Pavlin M (2009) Mechanisms involved in gene electrotransfer using high- and low-voltage pulses—an in vitro study. Bioelectrochemistry 74:265–271
Liew A, André FM, Lesueur L, De Ménorval M-A, O’Brien T, Mir LM (2013) Robust, efficient and practical electrogene transfer method for human mesenchymal stem cells using square electric pulses. Hum Gene Ther Methods 24(5):289–297
Joubert V, André FM, Schmeer M, Schleef M, Mir LM (2013) Increased efficiency of minicircles versus plasmids under gene electrotransfer suboptimal conditions: an influence of the extracellular matrix. In: Schleef M (ed) Minicircle and miniplasmid DNA vectors, the future of non-viral and viral gene transfer. Wiley-VCH, Weinheim, pp 215–225
André FM, Gehl J, Sersa G, Préat V, Hojman P, Eriksen J, Golzio M, Cemazar M, Pavselj N, Rols M-P, Miklavcic D, Teissié J, Mir LM (2008) High efficacy of high and low voltage pulse combinations for gene electrotransfer in muscle, liver, tumor and skin. Hum Gene Ther 19:1261–1271
Miklavcic D, Semrov D, Mekid H, Mir LM (2000) A validated model of in vivo electric field distribution in tissues for electrochemotherapy and for DNA electrotransfer for gene therapy. Biochim Biophys Acta 1523:73–83
Sel D, Mazeres S, Teissie J, Miklavcic D (2003) Finite-element modeling of needle electrodes in tissue from the perspective of frequent model computation. IEEE Trans Biomed Eng 50:1221–1232
Ivorra A, Mir LM, Rubinsky B (2009) Electric field redistribution due to conductivity changes during tissue electroporation: experiments with a simple vegetal model. IFMBE Proc 25:59–62
Ivorra A, Villemejane J, Mir LM (2010) Electrical modeling of the influence of medium conductivity on electroporation. Phys Chem Chem Phys 12:10055–10064
Ivorra A, Al-Sakere B, Rubinsky B, Mir LM (2009) In vivo electrical conductivity measurements during and after electroporation of sarcomas: conductivity changes reflect treatment outcome. Phys Med Biol 54:5949–5963
Kos B, Zupanic A, Kotnik T, Snoj M, Sersa G, Miklavcic D (2012) Robustness of treatment planning for electrochemotherapy of deep-seated tumors. J Membr Biol 236:147–153
Zupanic A, Kos B, Miklavcic D (2012) Treatment planning of electroporation-based medical interventions: electrochemotherapy, gene electrotransfer and irreversible electroporation. Phys Med Biol 57:5425–5440
Belehradek J Jr, Orlowski S, Ramirez LH, Pron G, Poddevin B, Mir LM (1994) Electropermeabilization of cells in tissues assessed by the qualitative and quantitative electroloading of bleomycin. Biochim Biophys Acta 1190:155–163
Tounekti O, Pron G, Belehradek J Jr, Mir LM (1993) Bleomycin, an apoptosis-mimetic drug that induces two types of cell death depending on the number of molecules internalized. Cancer Res 53:5462–5469
Poddevin B, Belehradek J Jr, Mir LM (1990) Stable [57Co]-bleomycin complex with a very high specific radioactivity for use at very low concentrations. Biochem Biophys Res Commun 173:259–264
Engstrom PE, Persson BR, Salford LG (1999) Studies of in vivo electropermeabilization by gamma camera measurements of (99m)Tc-DTPA. Biochim Biophys Acta 1473:321–328
Cukjati D, Batiuskaite D, André FM, Miklavčič D, Mir LM (2007) Real time electroporation level detection method for accurate and safe nonviral gene therapy. Bioelectrochemistry 70:501–507
Gehl J, Skovsgaard T, Mir LM (2002) Vascular reactions to in vivo electroporation: characterization and consequences for drug and gene delivery. Biochim Biophys Acta 1569:51–58
Ramirez LH, Orlowski S, An D, Bindoula G, Dzodic R, Ardouin P, Bognel C, Belehradek J Jr, Munck JN, Mir LM (1998) Electrochemotherapy on liver tumours in rabbits. Br J Cancer 77:2104–2111
Sersa G, Cemazar M, Parkins CS, Chaplin DJ (1999) Tumour blood flow changes induced by application of electric pulses. Eur J Cancer 35:672–677
Sersa G, Cemazar M, Miklavcic D, Chaplin DJ (1999) Tumor blood flow modifying effect of electrochemotherapy with bleomycin. Anticancer Res 19:4017–4022
André F, Mir LM (2004) DNA electrotransfer: its principles and an updated review of its therapeutic applications. Gene Ther 11(Suppl 1):S33–42
Mir LM, Moller PH, Andre F, Gehl J (2005) Electric pulse-mediated gene delivery to various animal tissues. Adv Genet 54:83–114
Peng B, Zhao Y, Lu H, Pang W, Xu Y (2005) In vivo plasmid DNA electroporation resulted in transfection of satellite cells and lasting transgene expression in regenerated muscle fibers. Biochem Biophys Res Commun 338:1490–1498
Liu F, Huang L (2002) A syringe electrode device for simultaneous injection of DNA and electrotransfer. Mol Ther 5:323–328
André FM, Mir LM (2010) Nucleic acids electrotransfer in vivo: mechanisms and practical aspects. Curr Gene Ther 4:267–280
Orlowski S, Belehradek J Jr, Paoletti C, Mir LM (1988) Transient electropermeabilization of cells in culture. Increase of the cytotoxicity of anticancer drugs. Biochem Pharmacol 37:4727–4733
Orlowski S, Mir LM (1993) Cell electropermeabilization: a new tool for biochemical and pharmacological studies. Biochim Biophys Acta 1154:51–63
Mir LM, Orlowski S, Belehradek J Jr, Paoletti C (1991) Electrochemotherapy potentiation of antitumour effect of bleomycin by local electric pulses. Eur J Cancer 27:68–72
Belehradek J Jr, Orlowski S, Poddevin B, Paoletti C, Mir LM (1991) Electrochemotherapy of spontaneous mammary tumours in mice. Eur J Cancer 27:73–76
Miklavcic D, Beravs K, Semrov D, Cemazar M, Demsar F, Sersa G (1998) The importance of electric field distribution for effective in vivo electroporation of tissues. Biophys J 74:2152–2158
Mir LM (2001) Therapeutic perspectives of in vivo cell electropermeabilization. Bioelectro-chemistry 53:1–10
Miklavcic D, Corovic S, Pucihar G, Pavselj N (2006) Importance of tumour coverage by sufficiently high local electric field for effective electrochemotherapy. Eur J Cancer Suppl 4:45–51
Ivorra A, Al-Sakere B, Rubinsky B, Mir LM (2008) Use of conductive gels for electric field homogenization increases the antitumor efficacy of electroporation therapies. Phys Med Biol 53:6605–6618
Čorović S, Al Sakere B, Haddad V, Miklavčič D, Mir LM (2008) Importance of contact surface between electrodes and treated tissue in electrochemotherapy. Technol Cancer Res Treat 7:393–400
Belehradek M, Domenge C, Luboinski B, Orlowski S, Belehradek J Jr, Mir LM (1993) Electrochemotherapy, a new antitumor treatment. First clinical phase I–II trial. Cancer 72:3694–3700
Domenge C, Orlowski S, Luboinski B, De Baere T, Schwaab G, Belehradek J Jr, Mir LM (1996) Antitumor electrochemotherapy: new advances in the clinical protocol. Cancer 77:956–963
Heller R, Jaroszeski MJ, Glass LF, Messina JL, Rapaport DP, DeConti RC, Fenske NA, Gilbert RA, Mir LM, Reintgen DS (1996) Phase I/II trial for the treatment of cutaneous and subcutaneous tumors using electrochemotherapy. Cancer 77:964–971
Mir LM, Devauchelle P, Quintin-Colonna F, Delisle F, Doliger S, Fradelizi D, Belehradek J Jr, Orlowski S (1997) First clinical trial of electrochemotherapy for the treatment of cat soft tissue sarcomas. Br J Cancer 76:1617–1622
Cemazar M, Tamzali Y, Sersa G, Tozon N, Mir LM, Miklavcic D, Lowe R, Teissie J (2008) Electrochemotherapy in veterinary oncology. J Vet Intern Med 22:826–831
Al-Sakere B, Bernat C, André F, Connault E, Opolon P, Davalos RV, Rubinsky B, Mir LM (2007) Tumor ablation with irreversible electroporation. PLoS One 2:e1135
Mahmood F, Gehl J (2011) Optimizing clinical performance and geometrical robustness of a new electrode device for intracranial tumor electroporation. Bioelectrochemistry 81:10–16
Sadadcharam M, Piggott J, Cogan L, Soden D, O'Sullivan GC (2007) Application of electroporation-driven intraluminal gene delivery. Hum Gene Ther 18:964–965
Daugimont L, Baron N, Vandermeulen G, Pavselj N, Miklavcic D, Jullien M-C, Cabodevila G, Mir LM, Préat V (2010) Hollow microneedle arrays for intradermal drug delivery and DNA electroporation. J Membr Biol 236:117–125
Tjelle TE, Salte R, Mathiesen I, Kjeken R (2006) A novel electroporation device for gene delivery in large animals and humans. Vaccine 24:4667–4670
Ferraro B, Heller LC, Cruz YL, Guo SQ, Donate A, Heller R (2011) Evaluation of delivery conditions for cutaneous plasmid electrotransfer using a multielectrode array. Gene Ther 18:496–500
Guo SQ, Donate A, Lundberg C, Heller L, Heller R (2011) Electro-gene transfer to skin using a noninvasive multielectrode array. J Control Release 151:256–262
Hargrave B, Downey H, Strange R, Murray L, Cinnamond C, Lundberg C, Israel A, Chen YJ, Marshall W, Heller R (2013) Electroporation-mediated gene transfer directly to the swine heart. Gene Ther 20:151–157
Gehl J, Mir LM (1999) Determination of optimal parameters for in vivo gene transfer by electroporation, using a rapid in vivo test for cell permeabilization. Biochem Biophys Res Commun 261:377–380
Hojman P, Gissel H, André FM, Cournil-Henrionnet C, Eriksen J, Gehl J, Mir LM (2008) Physiological effects of high and low voltage pulse combinations for gene electrotransfer in muscle. Hum Gene Ther 19:1249–1260
Schleef M (ed) (2013) Minicircle and miniplasmid DNA vectors, the future of non-viral and viral gene transfer. Wiley-VCH, Weinheim
Silve A, Leray I, Mir LM (2012) Demonstration of cell membrane permeabilisation to medium-sized molecules caused by a single 10 ns electric pulse. Bioelectrochemistry 87:260–264
Čorović S, Županič A, Kranjc S, Al Sakere B, Leroy-Willig A, Mir LM, Miklavčič D (2010) The influence of skeletal muscle anisotropy on electroporation: in vivo study and numerical modelling. Med Biol Eng Comput 48:637–648
Čorović S, Mir LM, Miklavčič D (2012) In vivo muscle electroporation threshold determination—realistic numerical models and in vivo experiments. J Membr Biol 245:509–520
Breton M, Mir LM (2012) Microsecond and nanosecond electric pulses in cancer treatments. Bioelectromagnetics 33:106–133
Villemejane J, Mir LM (2009) Physical methods of nucleic acids transfer—general concepts and applications. Br J Pharmacol 157:207–219
Acknowledgements
L.M. Mir acknowledges all his colleagues for stimulating discussions. The work of his team is conducted in the scope of the LEA EBAM (European Associated Laboratory on the Applications of the Electric pulses in Biology And Medicine). Activities are presently supported through grants of the ANR (IPSIOAT, INTCELL, MEMOVE) and of the ANSES (MARFEM).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media New York
About this protocol
Cite this protocol
Mir, L.M. (2014). Electroporation-Based Gene Therapy: Recent Evolution in the Mechanism Description and Technology Developments. In: Li, S., Cutrera, J., Heller, R., Teissie, J. (eds) Electroporation Protocols. Methods in Molecular Biology, vol 1121. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4614-9632-8_1
Download citation
DOI: https://doi.org/10.1007/978-1-4614-9632-8_1
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4614-9631-1
Online ISBN: 978-1-4614-9632-8
eBook Packages: Springer Protocols